DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹2,191 Cr | ₹1,600 Cr | ₹1,824 Cr | ₹2,960 Cr | ₹1,984 Cr |
What is the latest Profit After Tax of DIVIS LABORATORIES ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹2,191 Cr |
| Mar2024 | ₹1,600 Cr |
| Mar2023 | ₹1,824 Cr |
| Mar2022 | ₹2,960 Cr |
| Mar2021 | ₹1,984 Cr |
How is Profit After Tax of DIVIS LABORATORIES Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,191 Cr | 36.94 | |
| Mar2024 | ₹1,600 Cr | -12.28 | |
| Mar2023 | ₹1,824 Cr | -38.39 | |
| Mar2022 | ₹2,960 Cr | 49.19 | |
| Mar2021 | ₹1,984 Cr | - | |
Compare Profit After Tax of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹167,095.1 Cr | 2% | 4.8% | 4.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,054.0 Cr | 0.9% | 6.2% | -1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,904.0 Cr | 3.6% | 6% | 36.9% | Stock Analytics | |
| CIPLA | ₹107,358.0 Cr | -0.1% | -3% | -8.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,813.0 Cr | 1% | 10.8% | 4.7% | Stock Analytics | |
| MANKIND PHARMA | ₹84,111.1 Cr | -1.1% | -3% | -16.9% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 2% |
4.8% |
4.6% |
| SENSEX | -1.4% |
0.4% |
8.3% |
You may also like the below Video Courses